<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hedayati, Tarlan</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Diagnosis and Treatment of NSTEMI in 2014</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-13</style></pages><abstract><style  face="normal" font="default" size="100%">Acute coronary syndromes affect &gt;780000 individuals in the United States each year, 70% of which cases will be NSTEMI. This article discusses updates in the treatment of NSTE-ACS based on the 2014 American Heart Association / American College of Cardiology guideline for the management of patients with NSTE-ACS</style></abstract><number><style face="normal" font="default" size="100%">46</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>